SCHEMBL6593609

SCHEMBL6593609

COCCNCc1csc(C(=O)Nc2c(OC)cc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)c1Cl

nearest known ligand 0.85

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F2 P00734 19/20 0.85
F10 P00742 17/20 0.85
KLKB1 P03952 1/20 0.81
ELANE P08246 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6588731 0.93 F2 (0.85) F2F10KLKB1ELANE
SCHEMBL6596225 0.93 F2 (0.79) F2F10KLKB1ELANE
SCHEMBL6592954 0.93 F2 (0.83) F2F10KLKB1ELANE
SCHEMBL6592025 0.92 F2 (1.00) F2F10KLKB1ELANE
SCHEMBL6591079 0.91 F2 (0.81) F2F10KLKB1ELANE
SCHEMBL6593431 0.91 F2 (0.81) F2F10KLKB1ELANE
SCHEMBL6599106 0.91 F2 (0.80) F2F10KLKB1ELANE
SCHEMBL6599111 0.91 F2 (0.80) F2F10KLKB1ELANE
SCHEMBL6589576 0.90 F2 (1.00) F2F10KLKB1ELANE
SCHEMBL6593820 0.89 F2 (0.83) F2F10KLKB1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed